erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.may 17, 2018.. updated on: .fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and...